DA

Danish Alim Shaikh

Active Director Designated Partner DIN 10706545
DIN 10706545 First appointment Jul 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Danish Alim Shaikh

Data last updated:

Danish Alim Shaikh is a Designated Partner at Damin Pharmaceuticals Llp (since 2024). The company operates in Pharma.

DIN 10706545
Primary Designation Designated Partner
Industry Pharma
First Appointment 15 Jul 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner15 Jul 20242024Active

Board colleagues of Danish Alim Shaikh

NameDINCompanyDesignation
Bhavik Prakash Dhiravani10706544Damin Pharmaceuticals LlpDesignated Partner
Mahendra Hirji Shah00190008Damin Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Damin Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Danish Alim Shaikh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Danish Alim Shaikh

Danish Alim Shaikh currently holds 1 directorship: Damin Pharmaceuticals Llp (Designated Partner, since 15 Jul 2024).

Danish Alim Shaikh was first appointed on 15 Jul 2024 as Designated Partner at Damin Pharmaceuticals Llp.

The current boards of Danish Alim Shaikh's companies include Bhavik Prakash Dhiravani (Damin Pharmaceuticals Llp), Mahendra Hirji Shah (Damin Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available